Post-Transcriptional Changes in Serum Albumin: Role in the Pathogenesis of Bacterial Infections in Cirrhosis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  2016-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.6092/UNIBO/AMSDOTTORATO/7602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.

  2016cited by this paper
• Management of uninfected and infected ascites in cirrhosis

  2016cited by this paper
• Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury

  2015cited by this paper
• Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.

  2015cited by this paper
• Human Nonmercaptalbumin‐2: A Novel Prognostic Marker in Chronic Liver Failure

  2014cited by this paper
• Role of human albumin in the management of complications of liver cirrhosis.

  2014cited by this paper
• Cirrhosis and its complications: evidence based treatment.

  2014cited by this paper
• Management of hepatic encephalopathy in the hospital.

  2014cited by this paper
• A Fast and Validated Mass Spectrometry Method for the Evaluation of Human Serum Albumin Structural Modifications in the Clinical Field

  2013cited by this paper
• Effective albumin concentration and cirrhosis mortality: from concept to reality.

  2013cited by this paper
• Clinical indications for the albumin use: still a controversial issue.

  2013cited by this paper
• Report Title: The burden of liver disease in Europe: a review of available epidemiological data

  2013cited by this paper
• Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications

  2013cited by this paper
• Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

  2012cited by this paper
• Human serum albumin: from bench to bedside.

  2012cited by this paper
• Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.

  2011cited by this paper
• The glycation of albumin: structural and functional impacts.

  2011cited by this paper
• Systemic inflammatory response syndrome in patients with liver cirrhosis.

  2011cited by this paper
• Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

  2010cited by this paper
• Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

  2010cited by this paper
• S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia

  2009cited by this paper
• Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality

  2009cited by this paper
• Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis

  2009cited by this paper
• Complications of Cirrhosis

  2008cited by this paper
• Bacterial infections, sepsis, and multiorgan failure in cirrhosis.

  2008cited by this paper
• Oxidative damage of albumin in advanced liver disease.

  2008cited by this paper
• Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

  2008cited by this paper
• Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study.

  2008cited by this paper
• The antioxidant properties of serum albumin

  2008cited by this paper
• Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

  2007cited by this paper
• Assessment of low-grade hepatic encephalopathy: a critical analysis.

  2007cited by this paper
• Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis

  2007cited by this paper
• Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism.

  2006cited by this paper
• Formation of albumin dimers induced by exposure to peroxides in human plasma: a possible biomarker for oxidative stress.

  2006cited by this paper
• Heterogeneity and oxidation status of commercial human albumin preparations in clinical use*

  2005cited by this paper
• Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics.

  2004cited by this paper
• Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.

  2003cited by this paper
• Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

  2003cited by this paper
• Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite.

  2003cited by this paper
• An Essential Role for Albumin in the Interaction of Endotoxin with Lipopolysaccharide-binding Protein and sCD14 and Resultant Cell Activation*

  2002cited by this paper
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Review article: albumin for circulatory support in patients with cirrhosis

  2002cited by this paper
• A model to predict survival in patients with end‐stage liver disease

  2001cited by this paper
• Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia.

  2001cited by this paper
• Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

  2000cited by this paper
• Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation.

  2000cited by this paper
• Role of albumin and High-Density Lipoprotein as Endotoxin-Binding Proteins in Rats with Acute and Chronic Alcohol Loading

  1998cited by this paper
• Historical Aspects of Treatment of Patients with Cirrhosis and Ascites

  1997cited by this paper
• All About Albumin: Biochemistry, Genetics, and Medical Applications

  1995cited by this paper
• Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix.

  1993cited by this paper
• [Liver cirrhosis].

  1989cited by this paper
• Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

  1988cited by this paper
• Antioxidant defenses and lipid peroxidation in human blood plasma.

  1988cited by this paper
• Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites.

  1986cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• Nonenzymatic glycosylation of human serum albumin alters its conformation and function.

  1984cited by this paper
• Copper salt-dependent hydroxyl radical formation. Damage to proteins acting as antioxidants.

  1983cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper
• The effect of repeated albumin infusions in patients with cirrhosis.

  1962cited by this paper

• No citing papers are available for this paper.